3.11 Dose Volume Histograms (DVH) & QUANTEC Tissue Tolerances

Cumulative vs. Differential Dose-Volume Histograms

A Dose-Volume Histogram (DVH) summarizes 3D dose distribution data from a treatment planning system (TPS) into a 2D graph, plotting radiation dose on the horizontal axis ($X$-axis in Gy or %) against tissue volume on the vertical axis ($Y$-axis in % or $\text{cm}^3$).

Volume (%)
100% |===== (PTV Target Line) =====+
     |                             | \
80%  |                             |  \
     |    [ Parallel Organ: Lung ] |   \
60%  |----\                       |    \
     |    \                      |     \
40%  |     \                     |      + (D95 Target Coverage)
     |  [ Serial Organ: Cord ]   |      |
20%  |-------\                    |      |
     +-------+-------------------+------+--------> Dose (Gy)
     0       20 Gy               45 Gy  70 Gy

1. Cumulative (Integrating) Dose-Volume Histogram

The cumulative DVH is the standard clinical format. Each point $(D, V)$ on a cumulative curve represents the total volume of a structure receiving a dose equal to or greater than the corresponding dose value on the $X$-axis.

• PTV Target Curve: Ideal shape is a steep box-step curve where 100% of the target volume receives $\ge 95%$ of the prescription dose, then drops abruptly to 0% beyond 105% of the prescription dose.
• Organs at Risk (OAR) Curve: Ideal shape drops rapidly near 0 Gy, staying far to the left of target curves to demonstrate normal tissue sparing.

2. Differential Dose-Volume Histogram

Plots the volume of tissue receiving a dose within specific incremental dose bins (e.g., 1 Gy dose intervals). Differential DVHs are particularly useful for identifying bimodal dose distributions, detecting isolated localized hot spots, and analyzing dose gradients across target boundaries.

---

Essential Clinical DVH Parameters

Dosimetrists and radiation oncologists utilize specific numerical parameters extracted from cumulative DVHs to verify target coverage and restrict normal tissue toxicity:

• $V_D$ (Volume Constraint Metric): The percentage (or absolute volume in $\text{cm}^3$) of an organ receiving a dose $\ge D$ Gy.
  • $V_{20}$ for Lungs: Combined lung volume receiving $\ge 20\text{ Gy}$ (predicts radiation pneumonitis risk).
  • $V_{50}$ for Rectum: Rectal volume receiving $\ge 50\text{ Gy}$ (predicts Grade $\ge 2$ late rectal bleeding).
  • $V_{25}$ for Heart: Heart volume receiving $\ge 25\text{ Gy}$ (predicts long-term cardiac mortality).
• $D_{\max}$ (Maximum Point Dose / $D_{0.03\text{ cc}}$): Peak dose delivered to a tiny volume element ($0.03\text{ cc}$). Critical safety evaluation metric for serial organs where localized point damage causes complete organ failure.
• $D_{\text{mean}}$ (Mean Organ Dose): Volume-weighted average dose across an entire organ volume. Primary predictive metric for parallel organ toxicity.
• $D_{95}$ (Prescription Coverage Parameter): Minimum dose received by at least 95% of the PTV target volume. Standard metric for verifying target coverage.

---

Radiobiological Organ Architecture: Serial vs. Parallel Organs

Understanding normal tissue tolerance requires categorizing organs by Functional Subunit (FSU) architecture. A Functional Subunit is the basic structural and functional cellular group capable of performing organ work.

1. Serial Organs

Organized like links in a chain. Disruption of a single functional subunit at any location along the organ causes complete functional failure of the entire organ or catastrophic clinical damage.

• Critical Evaluation Metric: Maximum Point Dose ($D_{\max}$ or $D_{0.03\text{ cc}}$). Threshold dose limits must never be exceeded at any point.
• Clinical Examples: Spinal Cord (radiation myelopathy / transverse paralysis), Brainstem (neurological necrosis), Optic Chiasm / Optic Nerves (blindness), Femoral Heads (avascular necrosis and hip fracture).

2. Parallel Organs

Organized as independent parallel units operating side-by-side. The organ maintains overall function as long as a critical reserve volume of functional subunits remains undamaged.

• Critical Evaluation Metric: Mean Organ Dose ($D_{\text{mean}}$) and Fractional Volume Constraints ($V_D$).
• Clinical Examples: Lungs (radiation pneumonitis), Parotid Glands (severe permanent xerostomia / dry mouth), Liver (radiation-induced liver disease RILD), Kidneys (renal failure).

---

QUANTEC Normal Tissue Tolerances

The Quantitative Analysis of Normal Tissue Effects in the Clinic (QUANTEC) guidelines establish standardized, evidence-based dose-volume constraints for adult 3D-CRT and IMRT treatments delivered at standard fractionation (1.8 – 2.0 Gy per fraction).

Detailed Organ Toxicity & Constraint Summary

• Spinal Cord ($D_{\max} < 45 - 50\text{ Gy}$): Full cord point maximum dose must remain below 45–50 Gy. Exceeding 50 Gy causes demyelination and transverse myelopathy resulting in permanent paralysis.
• Brainstem ($D_{\max} < 54\text{ Gy}$): Brainstem maximum dose is capped at 54 Gy for the full organ volume to prevent brainstem necrosis and cranial nerve deficits.
• Optic Chiasm & Optic Nerves ($D_{\max} < 54\text{ Gy}$): Doses above 54 Gy (or 50 Gy at high fraction sizes) lead to severe optic neuropathy and permanent blindness.
• Parotid Glands (Mean $< 20\text{ Gy}$ / $< 25 - 26\text{ Gy}$): Restricting mean dose to $<20\text{ Gy}$ for one gland or $<25-26\text{ Gy}$ for both combined preserves baseline salivary flow and prevents permanent xerostomia.
• Rectum ($V_{50} < 50%$): Keeping the volume receiving $\ge 50\text{ Gy}$ under 50% ($V_{50} < 50%$) restricts Grade $\ge 2$ late rectal bleeding and proctitis.
• Heart ($V_{25} < 10%$, Mean $< 26\text{ Gy}$): Limiting heart volume receiving 25 Gy to $<10%$ spares cardiac muscle, preventing pericarditis, coronary artery disease, and late cardiac mortality.
• Femoral Heads ($D_{\max} < 52\text{ Gy}$): Keeping point maximum dose below 52 Gy prevents radiation-induced avascular necrosis of the femoral head and hip joint fracture.